Peripheral blood is commonly used for diagnostic purposes in cancer care. By analyzing components such as tumor markers, circulating tumor cells (CTCs), and other biomarkers, healthcare professionals can detect the presence of cancer, monitor its progression, and evaluate the effectiveness of treatments. Techniques such as liquid biopsy have revolutionized cancer diagnostics by providing a less invasive method to obtain crucial information.
